Introduction
Fragile X Syndrome - Overview
Fragile X Syndrome - Therapeutics Development
Fragile X Syndrome - Therapeutics Assessment
Fragile X Syndrome - Companies Involved in Therapeutics Development
Fragile X Syndrome - Drug Profiles
Fragile X Syndrome - Dormant Projects
Fragile X Syndrome - Discontinued Products
Fragile X Syndrome - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Fragile X Syndrome, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Fragile X Syndrome - Pipeline by Anavex Life Sciences Corp, H2 2020
Fragile X Syndrome - Pipeline by Anima Biotech Inc, H2 2020
Fragile X Syndrome - Pipeline by Autifony Therapeutics Ltd, H2 2020
Fragile X Syndrome - Pipeline by Confluence Pharmaceuticals LLC, H2 2020
Fragile X Syndrome - Pipeline by DRI Biosciences Corp, H2 2020
Fragile X Syndrome - Pipeline by Epigen Biosciences Inc, H2 2020
Fragile X Syndrome - Dormant Projects, H2 2020
Fragile X Syndrome - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Fragile X Syndrome, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020

Companies Mentioned
• Anavex Life Sciences Corp
• Anima Biotech Inc
• Autifony Therapeutics Ltd
• Confluence Pharmaceuticals LLC
• DRI Biosciences Corp
• Epigen Biosciences Inc
• GlaxoSmithKline Plc
• GW Pharmaceuticals Plc
• Healx Ltd
• Hua Medicine Shanghai Ltd
• Lysogene SAS
• Neuren Pharmaceuticals Ltd
• Neuron Biopharma SA
• Neurotrope Bioscience Inc
• Novartis AG
• Ovid Therapeutics Inc
• Paxmedica Inc
• Prilenia Therapeutics Development Ltd
• Prous Institute for Biomedical Research SA
• Recursion Pharmaceuticals Inc
• RespireRx Pharmaceuticals Inc
• Sentinel Oncology Ltd
• Seropeutics LLC
• Takeda Pharmaceutical Co Ltd
• Taysha Gene Therapies
• Tetra Therapeutics
• Triplet Therapeutics Inc
• Zynerba Pharmaceuticals Inc